Hims & Hers Health (HIMS) analyst forecast and price target
Analyst forecast
Consensus of 19 analyst ratings
Based on 9 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| JP Morgan | Initiated Coverage | Neutral | $32.00 | Sep 11, 2026 |
| Truist Securities | Maintained | Hold | $32.00 from $27.00 | Aug 24, 2026 |
| Barclays | Maintained | Overweight | $35.00 from $39.00 | Aug 21, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $28.00 from $21.00 | Aug 11, 2026 |
| Needham | Maintained | Buy | $42.00 from $35.00 | Aug 11, 2026 |
| TD Cowen | Maintained | Hold | $30.00 from $25.00 | Aug 11, 2026 |
| B of A Securities | Maintained | Neutral | $32.00 from $30.00 | Aug 11, 2026 |
| Deutsche Bank | Maintained | Hold | $26.00 from $25.00 | Aug 11, 2026 |
| Citigroup | Maintained | Neutral | $33.00 from $35.00 | Aug 11, 2026 |
| Truist Securities | Maintained | Hold | $27.00 from $23.00 | Jul 24, 2026 |
| Citigroup | Maintained | Neutral | $35.00 from $28.00 | Jul 23, 2026 |
| B of A Securities | Maintained | Neutral | $37.00 from $36.00 | Jul 9, 2026 |
| B of A Securities | Maintained | Neutral | $36.00 from $25.00 | Jul 1, 2026 |
| Canaccord Genuity | Maintained | Buy | $40.00 from $32.00 | Jul 1, 2026 |
| Barclays | Maintained | Overweight | $39.00 from $29.00 | Jun 18, 2026 |
| B of A Securities | Maintained | Neutral | $25.00 from $28.00 | May 26, 2026 |
| Truist Securities | Maintained | Hold | $23.00 from $18.00 | May 22, 2026 |
| B of A Securities | Maintained | Neutral | $28.00 from $30.00 | May 19, 2026 |
| B of A Securities | Maintained | Neutral | $30.00 from $32.00 | May 13, 2026 |
| BTIG | Maintained | Neutral | — | May 12, 2026 |
Frequently asked questions
What is the price target for HIMS stock?
The average 12-month analyst price target for Hims & Hers Health (HIMS) is $32.22, with a high estimate of $42.00 and a low of $26.00, across 9 analysts.
Is HIMS a buy, sell, or hold?
Analysts covering Hims & Hers Health currently average a Hold rating: 5 buy, 13 hold and 1 sell, from 19 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for HIMS?
The average price target of $32.22 implies 9.67% upside from the last price of $29.38.
What is the latest analyst rating on HIMS?
On Sep 11, 2026, JP Morgan initiated coverage of Hims & Hers Health at Neutral with a price target of $32.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.